Skip to Content
Merck
CN

EHU053141

Sigma-Aldrich

MISSION® esiRNA

targeting human MRPL13

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CTGGCAAACTTGCTGCTATGGCATCTATAAGACTTCAGGGATTACATAAACCTGTGTACCATGCACTGAGTGACTGTGGGGATCATGTTGTTATAATGAACACAAGACACATTGCATTTTCTGGAAACAAATGGGAACAAAAAGTATACTCTTCGCATACTGGCTACCCAGGTGGATTTAGACAAGTAACAGCTGCTCAGCTTCACCTGAGGGATCCAGTGGCAATTGTAAAACTAGCTATTTATGGCATGCTGCCAAAAAACCTTCACAGAAGAACAATGATGGAAAGGTTGCATCTTTTTCCAGATGAGTATATTCCAGAAGATATTCTTAAGAATTTAGTAGAGGAGCTTCCTCAACCACGAAAAATACCTAAACGTCTAGATGAGTACACACAAGAAGAAATAGACGCCTTCCCAAGATTGTGGACTCCACCTGAAGATTATCGGC

Ensembl | human accession no.

ENSG00000172172

NCBI accession no.

NM_014078

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... MRPL13(28998), MRPL13(28998)

Related Categories

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Miaomiao Cai et al.
Cancer management and research, 13, 2009-2024 (2021-03-05)
Breast cancer (BC), with varying histopathology, biology and response to systemic treatment, is the second leading cause of cancer-related mortality. Previous studies have inferred that the expression of mitochondrial ribosomal proteins (MRPs) is possibly related to the occurrence/progression of BC.
Zuo Tao et al.
OncoTargets and therapy, 13, 12255-12268 (2020-12-05)
To study the expression of MRPL13 in breast cancer tissues using TCGA database, analyze the correlation between the expression and clinicopathological characteristics of patients, and explore the role of MRPL13 in the development of breast cancer (BC). The BC mRNA

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service